Literature DB >> 4309018

Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.

C A Cape, R A Utterback.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309018      PMCID: PMC496515          DOI: 10.1136/jnnp.32.4.290

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration.

Authors:  D GROB; A M HARVEY
Journal:  Bull Johns Hopkins Hosp       Date:  1952-08

2.  Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

Authors:  C H MILLIKAN; L M EATON
Journal:  Neurology       Date:  1951 Mar-Apr       Impact factor: 9.910

3.  Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis.

Authors:  C TORDA; H G WOLFF
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-08

4.  Studies in myasthenia gravis. Short-term massive corticotropin therapy.

Authors:  K E Osserman; G Genkins
Journal:  JAMA       Date:  1966-11-14       Impact factor: 56.272

5.  Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.

Authors:  D Grob; T Namba
Journal:  JAMA       Date:  1966-11-14       Impact factor: 56.272

6.  Treatment of severe myasthenia gravis with large doses of ACTH.

Authors:  G von Reis; A Liljestrand; G Matell
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

  6 in total
  4 in total

1.  Benefit from adrenocorticotrophin in myasthenia gravis.

Authors:  L A Liversedge; G M Yuill; I M Wilkinson; J A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

2.  Myasthenia gravis, ulcerative colitis and lichen planus.

Authors:  T N Miller
Journal:  Proc R Soc Med       Date:  1971-08

3.  Treatment of ocular myasthenia with corticotrophin.

Authors:  F B Gibberd; F Navab; C L Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

4.  Myasthenia gravis and the myasthenic syndrome.

Authors:  C Herrmann
Journal:  Calif Med       Date:  1970-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.